ABIVAX
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer.
ABIVAX
Industry:
Biotechnology
Founded:
2013-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.abivax.com
Total Employee:
11+
Status:
Active
Contact:
+33(0)1 53 83 08 41
Total Funding:
96.2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Benchmark Holdings
Benchmark Holdings, a pioneering bioagtech company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Board_member
Current Employees Featured
Jean Marc Steens Chief Medical Officer @ Abivax
Chief Medical Officer
Pierre Courteille Founder, Chief Commercial Officer & Vice President of Business Development @ Abivax
Founder, Chief Commercial Officer & Vice President of Business Development
2015-04-01
Hartmut J. Ehrlich CEO @ Abivax
CEO
2013-12-01
Didier Blondel Chief Financial Officer @ Abivax
Chief Financial Officer
Founder
Stock Details
Investors List
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Abivax
Invus
Invus investment in Post-IPO Equity - Abivax
TCG Crossover
TCG Crossover investment in Post-IPO Equity - Abivax
Truffle Capital
Truffle Capital investment in Post-IPO Equity - Abivax
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Abivax
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Abivax
Kreos Capital
Kreos Capital investment in Post-IPO Debt - Abivax
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Abivax
Kreos Capital
Kreos Capital investment in Post-IPO Debt - Abivax
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-01 | Abivax appoints Dr Sophie Biguenet, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.abivax.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K
- Host name: 172.67.179.74
- IP address: 172.67.179.74
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abivax"
Investor Relations | Abivax
Jan 28, 2025 The Investor Relations website contains information about Abivax's business for stockholders, potential investors, and financial analysts.See details»
About Abivax
Abivax is a clinical-stage biotechnology company focused on harnessing the body’s natural regulatory mechanisms through enhanced expression of microRNA-124.See details»
Abivax - Crunchbase Company Profile & Funding
Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral …See details»
Our Leadership - Abivax
Abivax has an experienced leadership team with expertise in the scientific development and commercialization of therapeutics for chronic inflammatory diseases.See details»
Abivax - Wikipedia
Abivax focuses on the treatment of inflammatory bowel diseases, namely ulcerative colitis (UC) and Crohn’s disease (CD). Its lead drug candidate, obefazimod, is an oral, first-in-class, small …See details»
Abivax - LinkedIn
Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with ...See details»
ABIVAX Société Anonyme (ABVX) - Yahoo Finance Canada
See the company profile for ABIVAX Société Anonyme (ABVX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Abivax Announces Full Year 2024 Financial Results | Abivax
Dec 31, 2024 Abivax Announces Full Year 2024 Financial Results • Cash balance of EUR 144.2M as of December 31, 2024; cash runway into Q4 2025 Full enrollment in Phase 3 …See details»
Abivax Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Abivax has 5 employees across 2 locations. See insights on Abivax including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ABIVAX Société Anonyme Company Description - Stock Analysis
Dec 16, 2024 Company profile for ABIVAX Société Anonyme (EPA: ABVX) with a description, list of executives, contact details and other key facts.See details»
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONb
(Exact name of Registrant as specified in its charter and translation of Registrant’s name into English) France (Jurisdiction of incorporation or organization) 7-11 boulevard Haussmann …See details»
Company History | Abivax
Abivax has a history of following the science and recognizing its potential to address unmet needs, which enables continuous exploration and future possibilities.See details»
Abivax - VentureRadar
"Abivax is developing therapies that stimulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to …See details»
Abivax Provides Operational and Key Program Update
Jul 15, 2024 Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune …See details»
Abivax Announces Presentation of Seven Abstracts for
Jan 23, 2025 Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress PARIS, …See details»
Abivax - AccessTCA
The two shows targeted in the US are The American College of Gastroenterology (ACG), and Advances in Inflammatory Bowel Diseases (AIBD). In Europe, Abivax focused on the United …See details»
Abivax publishes financial reports with the French and U.S.
3 days ago Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune …See details»
Abivax publishes financial reports with the French and U.S.
4 days ago Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune …See details»
Our Mission - Abivax
The Abivax mission is to harness the power of microRNA biology to create transformative treatments for patients in need.See details»
ABIVAX: Undercovered, Late-Stage French Company With …
2 days ago ABIVAX is a French company that IPO-ed in the US in 2023 and is running a phase 3 trial for ulcerative colitis. Their lead candidate, obefazimod, is in phase 3 trials for moderate …See details»